At a glance
- Originator Gedeon Richter
- Class Antihypertensives; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor antagonists; Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 05 Aug 1997 Discontinued-I for Hypertension in Hungary (PO)
- 29 Mar 1995 Suspended-I for Hypertension in Hungary (PO)